Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector-Reference-Cited by-同舟云学术

Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector

Published:2020-10-25 Issue:2 Volume:4 Page:2000172
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Dube Taru¹,Ghosh Amrito¹,Mishra Jibanananda²,Kompella Uday B.³,Panda Jiban Jyoti¹³^ORCID

Affiliation:

1. Institute of Nano Science and Technology Mohali Punjab 160062 India

2. School of Bioengineering and Biosciences Lovely Professional University Phagwara Punjab 144411 India

3. Nanomedicine and Drug Delivery Laboratory Department of Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Aurora CO 80045 USA

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202000172

Reference165 articles.

1. The COVID‐19 epidemic

2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

3. World Health Organization 2020.Coronavirus disease (COVID‐19) weekly epidemiological update and weekly operational update.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ (accessed: September 2020).

4. World Health Organization 2020.COVID‐19 strategy update.https://www.who.int/publications-detail/covid-19-strategy-update-14-april-2020(accessed: September 2020).

5. World Health Organization 2020.Naming the coronavirus disease (COVID‐19) and the virus that causes it.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical‐guidance/naming‐the‐coronavirus‐disease‐(covid‐2019)‐and‐the‐virus‐ that‐causes‐it/ (accessed: September 2020).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of Nanoparticles With Proteins;Advances in Chemical and Materials Engineering;2024-06-30

2. The use of tocilizumab in severe COVID-19: A comprehensive review;Medicinska istrazivanja;2024

3. Challenges in development of antiviral drugs and vaccines;Pathogenic Viruses and Armamentarium Design;2024

4. Pairwise synthetic cytotoxicity between Paxlovid and 100 frequently prescribed FDA-approved small molecule drugs on liver cells;Toxicology and Applied Pharmacology;2023-10

5. Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities;Viruses;2023-08-28